IXC
Click for more information
5.26% 7.2¢ invex therapeutics ltd

University of Birmingham Lawsuit, page-54

  1. Mpk888
    325 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    23/07/21
    12:55
    Post #: 54720678
    From Company update -

    In June, the Company was made aware of a UK lawsuit filed by Exelogen, Inc. against the University
    of Birmingham in relation to certain intellectual property rights to Exenatide. Invex Therapeutics
    is not a party to this lawsuit, with all intellectual property rights to Exenatide patent applications
    assigned to Invex by the University of Birmingham on 12 March 2019.

    Pretty much all I need to hear.
    IXC Price at posting: 61.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢ 		Change
-0.004(5.26%) 		Mkt cap ! $5.411M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $2.243K 30.74K

Buyers (Bids)

No. Vol. Price($)
1 38792 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 12.37pm 22/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.